Alkeus Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch Alkeus Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of ALK-001 on the Progression of Stargardt Disease (NCT07419334) | Alkeus Pharmaceuticals, Inc. | 2026-06-01 |
| Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) (NCT04239625) | Alkeus Pharmaceuticals, Inc. | 2019-12-20 |
| Phase 2/3 Study of ALK-001 in Geographic Atrophy (NCT03845582) | Alkeus Pharmaceuticals, Inc. | 2019-05-07 |
| Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (NCT02402660) | Alkeus Pharmaceuticals, Inc. | 2015-08-01 |
| Phase 1 Safety Study of ALK-001 in Healthy Volunteers (NCT02230228) | Alkeus Pharmaceuticals, Inc. | 2014-04-01 |
Track Alkeus Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.